Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
quemliclustat (AB680)
i
Other names:
AB680, AB-680
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Arcus Biosci, Gilead, Otsuka, Takeda
Drug class:
CD73 inhibitor
Related drugs:
‹
MEDI9447 (6)
TJD5 (3)
INT-1B3 (1)
ABSK051 (0)
BMS-986179 (0)
BP1200 (0)
HB0045 (0)
HLX23 (0)
IPH5301 (0)
NZV930 (0)
ORIC-533 (0)
PM1015 (0)
S95024 (0)
AGEN1423 (0)
AK119 (0)
CPI-006 (0)
INCA00186 (0)
MEDI9447 (6)
TJD5 (3)
INT-1B3 (1)
ABSK051 (0)
BMS-986179 (0)
BP1200 (0)
HB0045 (0)
HLX23 (0)
IPH5301 (0)
NZV930 (0)
ORIC-533 (0)
PM1015 (0)
S95024 (0)
AGEN1423 (0)
AK119 (0)
CPI-006 (0)
INCA00186 (0)
›
Associations
News
Trials
Phase
Status
Apply
Phase
Status
Apply
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies (EDGE-Gastric) (NCT05329766)
Phase 2
Arcus Biosciences, Inc.
Arcus Biosciences, Inc.
Recruiting
Phase 2
Arcus Biosciences, Inc.
Recruiting
Last update posted :
06/05/2024
Initiation :
06/10/2022
Primary completion :
09/01/2026
Completion :
06/01/2027
PD-L1
|
PD-L1 expression
|
5-fluorouracil • oxaliplatin • Yutuo (zimberelimab) • leucovorin calcium • domvanalimab (AB154) • quemliclustat (AB680)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login